Suppr超能文献

单细胞RNA测序揭示了一个由三个基因组成的基因 panel,可预测甲状腺乳头状癌的诊断和预后,并与肿瘤免疫微环境相关。

Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.

作者信息

Chen Zuoyu, Wang Yizeng, Li Dongyang, Le Yuting, Han Yue, Jia Lanning, Yan Caigu, Tian Zhigang, Song Wenbin, Li Fuxin, Zhao Ke, He Xianghui

机构信息

Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.

Department of General Surgery, The People's Hospital of Liuyang, Changsha, China.

出版信息

Front Oncol. 2022 Mar 11;12:862313. doi: 10.3389/fonc.2022.862313. eCollection 2022.

Abstract

OBJECTIVE

The objective of this research was to screen prognostic related genes of thyroid papillary carcinoma (PTC) by single-cell RNA sequencing (scRNA-seq), to construct the diagnostic and prognostic models based on The Cancer Genome Atlas Thyroid Cancer (TCGA-THCA) data, and to evaluate the association between tumor immune microenvironment and the prognostic model.

METHOD

The differentially expressed genes (DEGs) and tumor evolution were analyzed by scRNA-seq based on public databases. The potential regulatory networks of DEGs related to prognosis were analyzed by multi-omics data in the THCA. Logistic regression and Cox proportional hazards regression were utilized to construct the diagnosis and prognostic model of PTC. The performance of the diagnostic model was verified by bulk RNA sequencing (RNA-seq) of our cohort. The tumor immune microenvironment associated with the prognostic model was evaluated using multi-omics data. In addition, qRT-PCR was performed on tumor tissues and adjacent normal tissues of 20 patients to verify the expression levels of DEGs.

RESULTS

The DEGs screened by scRNA-seq can distinguish between tumor and healthy samples. DEGs play different roles in the evolution from normal epithelial cells to malignant cells. Three DEGs ((, , and )) related to prognosis were filtered, which may be regulated by DNA methylation, RNA methylation (m6A) and upstream transcription factors. The area under curve (AUC) of the diagnostic model based on 3-gene in the validation of our RNA-seq was 1. In the prognostic model based on 3-gene, the overall survival (OS) of high-risk patients was shorter. Combined with the clinical information of patients, a nomogram was constructed by using tumor size (pT) and risk score to quantify the prognostic risk. The age and tumor size of high-risk patients in the prognostic model were greater. In addition, the increase of tumor mutation burden (TMB) and diversity of T cell receptor (TCR), and the decrease of CD8 T cells in high-risk group suggest the existence of immunosuppressive microenvironment.

CONCLUSION

We applied the scRNA-seq pipeline to focus on epithelial cells in PTC, simulated the process of tumor evolution, and revealed a prognostic prediction model based on 3 genes, which is related to tumor immune microenvironment.

摘要

目的

本研究旨在通过单细胞RNA测序(scRNA-seq)筛选甲状腺乳头状癌(PTC)的预后相关基因,基于癌症基因组图谱甲状腺癌(TCGA-THCA)数据构建诊断和预后模型,并评估肿瘤免疫微环境与预后模型之间的关联。

方法

基于公共数据库通过scRNA-seq分析差异表达基因(DEG)和肿瘤进化。利用THCA中的多组学数据分析与预后相关的DEG的潜在调控网络。采用逻辑回归和Cox比例风险回归构建PTC的诊断和预后模型。通过我们队列的批量RNA测序(RNA-seq)验证诊断模型的性能。使用多组学数据评估与预后模型相关的肿瘤免疫微环境。此外,对20例患者的肿瘤组织和癌旁正常组织进行qRT-PCR以验证DEG的表达水平。

结果

通过scRNA-seq筛选的DEG可区分肿瘤和健康样本。DEG在从正常上皮细胞向恶性细胞的进化中发挥不同作用。筛选出3个与预后相关的DEG((、和)),它们可能受DNA甲基化、RNA甲基化(m6A)和上游转录因子调控。在我们的RNA-seq验证中,基于3基因的诊断模型的曲线下面积(AUC)为1。在基于3基因的预后模型中,高危患者的总生存期(OS)较短。结合患者的临床信息,使用肿瘤大小(pT)和风险评分构建列线图以量化预后风险。预后模型中高危患者的年龄和肿瘤大小更大。此外,高危组中肿瘤突变负荷(TMB)增加、T细胞受体(TCR)多样性增加以及CD8 T细胞减少表明存在免疫抑制微环境。

结论

我们应用scRNA-seq流程聚焦于PTC中的上皮细胞,模拟肿瘤进化过程,并揭示了基于3个基因的预后预测模型,该模型与肿瘤免疫微环境相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc40/8962641/1fd7e1154e5f/fonc-12-862313-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验